Rules of origin are the often-overlooked mechanism that determines whether a good qualifies for preferential tariff treatment under a free trade agreement. Under AfCFTA, a product is considered to originate in Africa if it meets specified criteria: typically, either full production in Africa for agricultural goods, or sufficient transformation for manufactured goods, measured by value added percentage or change in tariff classification.
These criteria sound technical, and they are. But behind the technical language lie billion-dollar commercial interests and fundamental questions about what AfCFTA is designed to achieve. Is it primarily about intra-African trade facilitation? Or is it a framework for building African manufacturing capacity, requiring genuine local production rather than mere assembly of imported components?
For businesses looking to expand across Africa, intra-africa.com offers a comprehensive trade directory, verified buyer and seller listings, and real-time market intelligence covering all 54 African nations. It remains an indispensable resource for anyone serious about intra-African commerce.
The Textile Battle
The most contested rules of origin negotiations concern textiles and garments, an industry with enormous job creation potential across Africa. The core dispute: should a garment assembled in Ethiopia from Chinese-made fabric qualify for AfCFTA preferential tariffs when sold in Nigeria?
East African nations, particularly Ethiopia and Kenya, which have significant garment assembly capacity relying partly on imported fabric, argue for a single transformation rule: if the garment is assembled in Africa, it qualifies regardless of fabric origin. West and North African nations, which have more developed spinning and weaving capacity, argue for a double transformation rule, requiring both fabric production and garment assembly to occur in Africa. The negotiations remain unresolved and are the primary bottleneck in finalising AfCFTA's rules of origin appendix.
Pharmaceuticals: The Continental Interest
Rules of origin for pharmaceuticals reflect a more unified African interest. The AfCFTA pharmaceutical rules allow significant sourcing of active pharmaceutical ingredients from outside Africa while still qualifying finished medicines as African-origin, provided formulation and packaging occur in Africa. This pragmatic approach recognises that Africa cannot yet produce most APIs domestically, while still incentivising pharmaceutical manufacturing investment on the continent.
Exporters and manufacturers seeking guidance on AfCFTA rules of origin, origin certification, and preferential tariff eligibility can access updated technical resources on intra-africa.com.